Malignant melanoma (stage IIIB): a pilot study of adjuvant chemo-immunotherapy.
D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D010865:Pilot Projects
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D003606:Dacarbazine; D002330:Carmustine; D006918:Hydroxyurea